Extract notice to the Minister
Dupixent (prurigo nodulaire)
Common name / Subject : dupilumab
Name of the manufacturer : SanofiAven
Form : Sol. Inj. S.C. (ser); Sol. Inj. S.C. (stylo)
Dosage : ser : 150 mg/ml (2 ml); stylo : 150 mg/ml (2 ml)
Name of the manufacturer : SanofiAven
Form : Sol. Inj. S.C. (ser); Sol. Inj. S.C. (stylo)
Dosage : ser : 150 mg/ml (2 ml); stylo : 150 mg/ml (2 ml)
Indication : Prurigo nodulaire modéré à grave
INESSS' Recommendation
Inscription - Sous conditions
Minister's decisions
Surseoir à la décision (2025-09-25)
Evaluation published on August 27, 2025